Skip to main content

Advertisement

Log in

Treatment of Fetal Supraventricular Tachycardia

  • Pediatric Congenital Heart Disease (G Singh, Section Editor)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Fetal arrhythmia is a common reason for referral to fetal cardiology. Fetal supraventricular tachycardia can be subdivided into several groups with the most common being re-entrant supraventricular tachycardia and atrial flutter. Fetal tachycardia can lead to hydrops fetalis, which increases the risk of fetal demise, perinatal morbidities, and premature delivery. The diagnosis of fetal tachycardia can be a challenge as a traditional electrocardiogram cannot be completed on a fetus, and other methods must be used by fetal echocardiogram. Several retrospective studies have been completed to determine the best treatment; however, there continues to be no consensus on the best option. Digoxin, flecainide, and sotalol are commonly used and have favorable results depending on gestational age, fetal well-being, and presence of hydrops. Treatment in a timely manner can convert supraventricular tachycardia to a normal fetal heart rate, and hydrops can resolve with delivery at term if the proper medications are used.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Bianchi DW, Crombleholme TM, D’Alton ME, Malone FD. “Tachyarrhythmias.” Fetology: diagnosis & management of the fetal patient. New York: McGraw-Hill, Medical Pub. Division; 2000. p. 313–9. Print.

    Google Scholar 

  2. Hornberger LK, Sahn DJ. Rhythm abrnormalities of the fetus. Heart. 2007;93:1294–300.

    Article  PubMed  PubMed Central  Google Scholar 

  3. • Donofrio MT, Moon-Grady AJ, Hornberger LK, et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129:2183–242. This statement is a great reference for all of fetal cardiology. It describes not only fetal arrhythmia and treatment choices but describes different types of heart disease and how to treat and follow/manage patients.

  4. Jaeggi E. Electrophysiology for the perinatologist. In: Yagel S, Silverman N, Gembruch U, editors. Fetal cardiology: embryology, genetics, physiology, echocardiographic evaluation, diagnosis and perinatal management of cardiac diseases. 2nd ed. New York: Informa Healthcare USA; 2009. p. 435–48.

    Google Scholar 

  5. Gembruch U. Fetal tachyarrhtyhmia. In: Yagel S, Silverman N, Gembruch U, editors. Fetal cardiology: embryology, genetics, physiology, echocardiographic evaluation, diagnosis and perinatal management of cardiac diseases. 2nd ed. New York: Informa Healthcare USA; 2009. p. 461–81.

    Google Scholar 

  6. Jaeggi E, Ohman A. Fetal and neonatal arrhythmias. Clin Perinatol. 2016;43:99–112.

    Article  PubMed  Google Scholar 

  7. Matta M, Cuneo B. Doppler echocardiography for managing fetal cardiac arrhythmia. Clin Obstet Gynecol. 2010;53(4):899–914.

    Article  PubMed  Google Scholar 

  8. Wacker-Gussmann A, Strasburger JF, Cuneo BF, Wakai RT. Diagnosis and treatment of fetal arrhythmia. Am J Perinatol. 2014;31(7):617–28.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Jaeggi E, Fouron JC, Fournier A, et al. Ventriculo-atrial time interval measured on M mode echocardiography: a determining element, diagnosis, treatment, and prognosis of fetal supraventricular tachycardia. Heart. 1998;79(6):582–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Fouron JC. Fetal arrhythmias: the Saint-Justine Hospital Experience. Prenat Diagn. 2004;24(13):1068–80.

    Article  PubMed  Google Scholar 

  11. Nii M, Hamilton RM, Fenwick L, et al. Assessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiography. Heart. 2006;92(12):1831–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cuneo BF, Strasburger JF, Yu S, et al. In utero diagnosis of long QT syndrome by magnetocardiograpy. Circulation. 2013;128(20):2183–91.

    Article  PubMed  Google Scholar 

  13. Jaeggi E, Carvalho J, De Groot E, et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation. 2011;124:1747–54.

    Article  CAS  PubMed  Google Scholar 

  14. Cuneo BF. Treatment of fetal tachycardia. Heart Rhythm. 2008;5(8):1216–8.

    Article  PubMed  Google Scholar 

  15. Ebenroth ES, Cordes TM, Darragh RK. Second-line treatment of fetal supraventricular tachycardia using flecainide acetate. Pediatr Cadiol. 2001;22:283–487.

    Google Scholar 

  16. Van Engelen AD, Weijtens O, Brenner JI. Management outcome and follow up of fetal tachycardia. J Am Coll Cardiol. 1994;24:1371–5.

    Article  PubMed  Google Scholar 

  17. Oudijk MA, Michon MM, Kleinman CS, et al. Sotalol in the treatment of fetal dysrhythmias. Circulation. 2000;101:2721–6.

    Article  CAS  PubMed  Google Scholar 

  18. • Strizek B, Berg C, Gottschalk I, et al. High dose flecainide is the most effective treatment of fetal supraventricular tachycardia. Heart Rhythm. 2016;13(16):1283–8. Recent article suggesting flecianide is the best first line treatment for fetal supraventricular tachycardia.

  19. Allan LD, Chita SK, Sharland GK, et al. Flecainide in the treatment of fetal tachycardia. Br Heart J. 1991;65:46–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Strasburger J, Cuneo B, Michon M, Gottiener N, et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation. 2004;109:375–9.

    Article  CAS  PubMed  Google Scholar 

  21. Younis JS, Granat M. Insufficient transplacental digoxin transfer in severe hydrops fetalis. Am J Obstet Gynecol. 1987;157:1268–9.

    Article  CAS  PubMed  Google Scholar 

  22. Parilla BV, Strasburger JF, Socol ML. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy. Am J Perinatol. 1996;13:483–6.

    Article  CAS  PubMed  Google Scholar 

  23. Bourget P, Pons JC, Delouis C, Fermont L, et al. Flecainide distribution, transplacental passage, and accumulation in the amniotic fluid during the third trimester of pregnancy. Ann Pharmacother. 1994;28:1031–4.

    Article  CAS  PubMed  Google Scholar 

  24. Ghidini A, Sepulveda W, Lockwood CJ, et al. Complications of fetal blood sampling. Am J Obstet Gynecol. 1993;168:1339–44.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bridget B. Zoeller MD.

Ethics declarations

Conflict of Interest

The author declares that she has no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Pediatric Congenital Heart Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zoeller, B.B. Treatment of Fetal Supraventricular Tachycardia. Curr Treat Options Cardio Med 19, 7 (2017). https://doi.org/10.1007/s11936-017-0506-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11936-017-0506-x

Keywords

Navigation